# TILA-TACE in Treatment of Hepatocellular Carcinoma

> **NCT03910140** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 2000 (estimated)

## Conditions studied

- Tumor Response Rate
- Overall Survival

## Interventions

- **PROCEDURE:** TILA-TACE treatment

## Key facts

- **NCT ID:** NCT03910140
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2019-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03910140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03910140, "TILA-TACE in Treatment of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03910140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*